Annual Operating Expenses
$14.42 M
+$1.41 M+10.82%
December 1, 2023
Summary
- As of February 7, 2025, ZVSA annual total operating expenses is $14.42 million, with the most recent change of +$1.41 million (+10.82%) on December 1, 2023.
- During the last 3 years, ZVSA annual operating expenses has risen by +$2.59 million (+21.87%).
- ZVSA annual operating expenses is now at all-time high.
Performance
ZVSA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.27 M
-$484.40 K-17.59%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA quarterly total operating expenses is $2.27 million, with the most recent change of -$484.40 thousand (-17.59%) on September 1, 2024.
- Over the past year, ZVSA quarterly operating expenses has dropped by -$557.00 thousand (-19.71%).
- ZVSA quarterly operating expenses is now -55.93% below its all-time high of $5.15 million, reached on June 30, 2023.
Performance
ZVSA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ZVSA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.8% | -19.7% |
| 3 y3 years | +21.9% | +20.5% |
| 5 y5 years | +21.9% | +20.5% |
ZVSA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.2% | -55.9% | +27.8% |
| 5 y | 5-year | at high | +87.2% | -55.9% | +27.8% |
| alltime | all time | at high | +87.2% | -55.9% | +27.8% |
ZyVersa Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.27 M(-17.6%) |
| Jun 2024 | - | $2.75 M(-2.6%) |
| Mar 2024 | - | $2.83 M(+59.1%) |
| Dec 2023 | $14.42 M(+10.8%) | $1.78 M(-38.8%) |
| Sep 2023 | - | $2.90 M(-43.6%) |
| Jun 2023 | - | $5.15 M(+12.1%) |
| Mar 2023 | - | $4.59 M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $13.01 M(+68.9%) | $4.37 M(+28.6%) |
| Sep 2022 | - | $3.40 M(+80.3%) |
| Jun 2022 | - | $1.88 M(-44.1%) |
| Mar 2022 | - | $3.37 M(+89.6%) |
| Dec 2021 | $7.70 M(-34.9%) | - |
| Dec 2021 | - | $1.78 M(-16.0%) |
| Sep 2021 | - | $2.11 M |
| Dec 2020 | $11.83 M | - |
FAQ
- What is ZyVersa Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual operating expenses year-on-year change?
- What is ZyVersa Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly operating expenses year-on-year change?
What is ZyVersa Therapeutics annual total operating expenses?
The current annual operating expenses of ZVSA is $14.42 M
What is the all time high annual operating expenses for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual total operating expenses is $14.42 M
What is ZyVersa Therapeutics annual operating expenses year-on-year change?
Over the past year, ZVSA annual total operating expenses has changed by +$1.41 M (+10.82%)
What is ZyVersa Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ZVSA is $2.27 M
What is the all time high quarterly operating expenses for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly total operating expenses is $5.15 M
What is ZyVersa Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ZVSA quarterly total operating expenses has changed by -$557.00 K (-19.71%)